December 20, 2023 01:14 PM EST

FDA encourages collaboration between monoclonal antibody sponsors to keep pace with emerging Covid variants

The FDA is encouraging developers of Covid-19 monoclonal antibodies to collaborate and better target emerging variants in

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA en­cour­ages col­lab­o­ra­tion be­tween mon­o­clon­al an­ti­body spon­sors to keep pace with emerg­ing Covid vari­ants